Relative importance of enhanced glucose uptake versus attenuation of long-chain acyl carnitines in protecting ischemic myocardium

Coronary Artery Disease

Volumn 13, Issue 6, 2002, Pages 313-318

  Hwang, Yuying C ^a   Bakr, Soliman ^a   Ramasamy, Ravichandran ^a   Bergmann, Steven R ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Glucose; Ischemic myocardium; Long chain acyl carnitines

Indexed keywords

ALBUMIN; CARNITINE; CREATINE KINASE; CYTOCHALASIN B; GLUCOSE; NICOTINIC ACID; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PACING; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARNITINE; CREATINE KINASE; CYTOCHALASIN B; DISEASE MODELS, ANIMAL; GLUCOSE; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NIACIN; OXYGEN CONSUMPTION; RATS; RECOVERY OF FUNCTION; STROKE VOLUME; VASODILATOR AGENTS; VENTRICULAR PRESSURE;

EID: 0036760228     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200209000-00002     Document Type: Article

References (30)

1. Ramasamy R, Bergmann SR. Is myocardial protection effective? In: DeBono D, Sobel BE, (editors): Challenges in Acute Coronary Syndromes. Oxford: Blackwell Science, 2001. pp. 253-268.
2. Diaz F, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latino America) collaborative group. Circulation 1998; 96:2227-2234.
3. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 1997; 96:1152-1156.
4. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997; 33:243-257.
5. 31P-NMR study of isolated rat hearts. Am J Physiol 1991; 261(30):H469-H478.
6. Vanoverschelde J-LJ, Janier MF, Bergmann SR. The relative importance of myocardial energy metabolism compared with ischemic contracture in the determination of ischemic injury in isolated rabbit hearts. Circ Res 1994; 74:817-828.
7. Vanoverschelde JL, Janier MF, Bakke JE, Marshall DR, Bergmann SP. et al. Rate of glycolysis during ischemia determine extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994; 267;H1785-H1794.
8. Ramasamy R, Oates PJ, Schaefer S. Aldose reductase inhibition protects diabetic and non-diabetic rat hearts from ischemic injury. Diabetes 1997; 46:292-300.
9. Ramasamy R, Trueblood NA, Schaefer S. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion. Am J Physiol 1998; 275;H195-H203.
10. Schaefer S, Prussel E, Carr LJ. Requirement of glycolytic substrate for metabolic recovery during moderate low flow ischemia. J Mol Cell Cardiol 1995; 27:2167-2176.
11. Janier MF, Vanoverschelde JL, Bergmann SR. Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanisms. Am J Physiol 1993; 264:H163-H170.
12. Broderick TL, Quinney HA, Lopaschuk GD. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 1992; 267:3758-3763.
13. Molaparast-Saless F, Liedtke AJ, Nellis SH. Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium. J Mol Cell Cardiol 1987; 19:509-520.
14. Liedtke AJ, Nellis SH, Mjos OD. Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. Am J Physiol 1984; 247:H387-H394.
15. Broderick TL, Panagakis G, DiDomenico D, Gamble J, Lopaschuk GD, Shug AL, Paulson DJ. L-carnitine improvement of cardiac function is associated with stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts. Cardiovasc Res 1995: 30;815-820.
16. Lopaschuk GD. Alterations in myocardial fatty metabolism contribute to ischemic injury in the diabetic. Can J Cardiol 1989; 5:315-320.
17. Lopaschuk GD, Hansen CA, Neely JR. Fatty acid metabolism in hearts containing elevated levels of CoA. Am J Physiol 1986; 250;H351-H359.
18. Bergmann SR, Ferguson TBJ, Sobel BE. Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts. Am J Physiol 1981; 240:H229-H237.
19. Lerner E, Shug AL, Elson C, Shrago E. Reversible inhibition of adenine nucleotide translocation by long-chain fatty acyl coenzyme A esters in liver mitochondria of diabetic and hibernating animals. J Biol Chem 1972; 247;1513-1519.
20. Broderick TL, Quinney HA, Lopaschuk GD. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart. Cardiovasc Res 1995; 29:373-378.
21. Lopaschuk GD, Wall SR, Olley PM, Davies NJ. Entomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid induced ischemic injury independent of changes in long-chain acylcarnitine. Circ Res 1988; 63:1036-1043.
22. Zarain-Herzberg A, Rupp H, Dhalla NS. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB J 1996; 10:1303-1309.
23. Ramasamy R, Hwang YC, Bakr S, Bergmann SR. Protection of ischemic myocardium by inhibition of fatty acid uptake. Cardiovasc Res 2001; 51:275-282.
24. Ramasamy R, Hwang YC, Whang J, Bergmann SR. Protection of ischemic hearts by high glucose is mediated by the glucose transporter, GLUT-4. Am J Physiol 2001; 261:H290-H297.
25. Janier MF, Vanoverschelde J-LJ, Bergmann SR. Ischemic preconditioning stimulates anaerobic glycolysis in the isolated rabbit heart. Am J Physiol 1994; 267:H1353-H1360.
26. Fields LE, Daugherty A, Bergmann SR. Effect of fatty acid on performance and lipid content of hearts from diabetic rabbits. Am J Physiol 1986; 250:H1079-H1085.
27. Dhalla NS, Elimban V, Rupp H. Paradoxical role of lipid metabolism in heart function and dysfunction. Mol Cell Biochem 1992; 116:3-9.
28. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981; 23:321-336.
29. King LM, Opie LH. Glucose and glycogen utilization in myocardial ischemia - Changes in metabolism and consequences for the myocyte. Mol Cell Biochem 1998; 160:3-26.
30. Salaris S, Ramasamy R, Bergmann SR. Fructose-2,6-bisphosphate, a potent stimulator of phosphofructokinase, is increased by high exogenous glucose perfusion. Coron Artery Dis 2000; 11: 279-286.